21 – 30 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Symptoms predictive of Fusobacterium necrophorum pharyngotonsillitis – an observational study of cases presenting to hospitals in Southern Sweden
(
- Contribution to journal › Article
-
Mark
Perivascular phosphorylated TDP-43 inclusions are associated with Alzheimer's disease pathology and loss of CD146 and Aquaporin-4
2024) In Brain Pathology(
- Contribution to journal › Article
-
Mark
Okinawa-Based Nordic Diet Decreases Plasma Glial Fibrillary Acidic Protein Levels in Type 2 Diabetes Patients
(
- Contribution to journal › Article
- 2023
-
Mark
Contraction of human brain vascular pericytes in response to islet amyloid polypeptide is reversed by pramlintide
(
- Contribution to journal › Article
-
Mark
Diabetic Neuropathy assessed with Multifrequency Vibrometry Develops Earlier than Nephropathy but Later than Retinopathy
(
- Contribution to journal › Article
-
Mark
Plasma IAPP-Autoantibody Levels in Alzheimer’s Disease Patients Are Affected by APOE4 Status
(
- Contribution to journal › Article
-
Mark
Does fatigue in Parkinson’s disease impact one’s physical function in daily live?
2023) The 2023 Inational Congress of Parkinson’s Disease and Movement Disorderst(
In Movement Disorders 38(Suppl 1). p.824-824- Contribution to journal › Published meeting abstract
-
Mark
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
(
- Contribution to journal › Article
-
Mark
Development of the Swedish anticholinergic burden scale (Swe-ABS)
(
- Contribution to journal › Article
-
Mark
Rates of Progression in Patients with Alzheimer’s Disease Depending on Apolipoprotein E Genotype and Concomitant Medications.
2023) 16th Clinical Trials on Alzheimer's Disease Conference(
- Contribution to conference › Poster